Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 210 results for "lupin ltd"

Lupin launches Salix Pharma's Zaxine in Canada
Livemint.com

Lupin Ltd. Launches Zaxine In Canada

/PRNewswire/ -- Pharma Major Lupin Limited announced today that its Canadian subsidiary, Lupin Pharma Canada Limited (collectively Lupin) has launched its first Brand product Zaxine® under a strategic licensing agreement with the North Carolina ... BioSpace, 1 week ago
Lupin Launches Zaxine® in Canada Barchart, 1 week ago
[x]  
DNA India

Lupin's FY15 results on May 13, 2015

Lupin Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 13, 2015, inter alia, to consider the standalone and consolidated audited financial results for the year ended March 31, 2015 and recommend dividend, if any.
 Money Control1 week ago Senju Pharm. Co., Ltd. v. Lupin Ltd.  JD Supra1 week ago Lupin extends fall after Aurobindo gets USFDA nod for Generic Suprax  Smart Investor2 weeks ago Lupin's loss is Aurobindo's gain  Smart Investor2 weeks ago
[x]  

MFs offload Lupin, TCS and Motilal Oswal shares

Mutual fund houses offloaded shares of pharmaceutical major Lupin Ltd, information technology (IT) giant Tata Consultancy Services (TCS) and Motilal Oswal Financial Services over the last two months. While fund managers reduced their cash holdings ...
 Smart Investor1 week ago

Deferential Review for District Court Obviousness Determination

Senju Pharm. Co. v. Lupin Ltd. Addressing the issue of obviousness, the U.S. Court of Appeals for the Federal Circuit adopted a deferential review stance toward the district court's characterization of several prior art references and ultimately ...
 National Law Review2 days ago

LUPIN : Follow-up call: competition will bite

Lupin Ltd is expected to face stiff competition from the launch of generic Suprax by Aurobindo Pharmaceuticals . The US Food and Drug Administration (FDA) has approved the generic version of Aurobindo. Lupin derives 95 percent of the ...
 4 Traders2 weeks ago 4/20/15 - LUPIN - FOLLOW-UP CALL: COMPETITION WILL BITE  Pharmacy Choice1 week ago
Livemint.com

Live market updates: Sensex falls 100 points, DLF down 4.5% [Mint, New Delhi]

April 24--1:00pm: State Bank of India 12:40pm: Jet Airways Ltd loses 5% to Rs.391.55 after a newspaper reported Jet Airways has puts its wide-body fleet on sale to reduce debt. 12:20pm: Lupin Ltd 12:05pm: The S&P BSE Sensex has trimmed losses ...
 BusinessWeek1 week ago Live market updates: Sensex posts worst weekly fall in nearly four-and-a-half months  Livemint.com1 week ago Live market updates: Sensex rises 90 points, banking stocks jump [Mint, New Delhi]  BusinessWeek3 weeks ago
Livemint.com

Wockhardt to recall some products manufactured in India from US [Mint, New Delhi]

April 28--MUMBAI -- Mumbai-based generic drug maker Wockhardt Ltd The US drug regulator had banned drug imports from Wockhardt's two plants in 2013 citing flawed manufacturing processes. The drug maker on Tuesday said that during the last USFDA ...
 Bloomberg6 days ago

Pullback in Nifty likely next week; top 5 bets

NEW DELHI: After falling for three straight weeks and over 300 points in the month of April alone, the 50-share Nifty index is looking oversold, and chances of a bounce back are much higher in the coming week, say analysts. The April series started ...
 Economic Times2 days ago Chances of ‘pullback’ in Nifty much higher next week; 5 bets  Economic Times2 days ago

Federal Circuit Review | April 2015

No Recovery Of Lost Profits From Related Companies Activities In WARSAW ORTHOPEDIC, INC. v. NUVASIVE, INC. , Appeal Nos. 2013-1576, -1577, the Federal Circuit held that a company was not entitled to lost profits based on the activities of ...
 JD Supra5 days ago
NDTV Profit

Ready to pay 'Reasonable' Royalty to Novartis AG: Cipla to High Court

New Delhi : Indian pharma firm Cipla today suggested to the Delhi High Court that it was ready to pay "reasonable" royalty to Switzerland-based drug major Novartis AG if it is allowed to manufacture respiratory disease drug, 'Indaflo', which could ...
 NDTV Profit6 days ago Ready to pay "reasonable" royalty to Novartis AG: Cipla to HC  ZeeNews.com6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less